FHIR © HL7.org  |  FHIRsmith 0.18.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.terminology
Resource TypeCodeSystem
IdCodeSystem-detectedissue-clinical-impact.json
FHIR VersionR5
Sourcehttps://build.fhir.org/ig/HL7/UTG/CodeSystem-detectedissue-clinical-impact.html
URLhttp://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact
Version1.0.0
Statusactive
Date2026-09-14
NameDetectedIssueClinicalImpact
TitleDetected Issue Clinical Impact
Realmuv
Authorityhl7
DescriptionCodes that describe the potential clinical impact of a detected issue.
CopyrightThis material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license
Contentcomplete

Resources that use this resource

ValueSet
hl7.terminology#currentdetectedissue-clinical-impactDetected Issue Clinical Impact

Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem detectedissue-clinical-impact

This case-sensitive code system http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact defines the following codes:

CodeDisplayDefinition
increased-effect Increased effectThe clinical or pharmacologic effect is expected to be increased for one or more implicated therapies.
decreased-effect Decreased effectThe clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies.
mixed-effect Mixed effectMixed or differing changes in clinical or pharmacologic effects are expected.
adverse-reaction Adverse reactionAn adverse reaction is expected or its risk is increased.
additive-adverse-effects Additive adverse effectsAdverse or undesirable effects are expected to be additive for one or more implicated therapies.
avoid-concurrent-use Avoid concurrent use when possibleConcurrent use should generally be avoided because of the identified clinical risk.
contraindicated-in-some-patients Contraindicated in some patientsConcurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances.

Source1

{
  "resourceType": "CodeSystem",
  "id": "detectedissue-clinical-impact",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode": "cds"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode": "trial-use"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger": 3
    }
  ],
  "url": "http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact",
  "version": "1.0.0",
  "name": "DetectedIssueClinicalImpact",
  "title": "Detected Issue Clinical Impact",
  "status": "active",
  "experimental": false,
  "date": "2026-09-14",
  "publisher": "Health Level Seven International",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org"
        },
        {
          "system": "email",
          "value": "hq@HL7.org"
        }
      ]
    }
  ],
  "description": "Codes that describe the potential clinical impact of a detected issue.",
  "copyright": "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license",
  "caseSensitive": true,
  "valueSet": "http://terminology.hl7.org/ValueSet/detectedissue-clinical-impact",
  "content": "complete",
  "concept": [
    {
      "code": "increased-effect",
      "display": "Increased effect",
      "definition": "The clinical or pharmacologic effect is expected to be increased for one or more implicated therapies."
    },
    {
      "code": "decreased-effect",
      "display": "Decreased effect",
      "definition": "The clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies."
    },
    {
      "code": "mixed-effect",
      "display": "Mixed effect",
      "definition": "Mixed or differing changes in clinical or pharmacologic effects are expected."
    },
    {
      "code": "adverse-reaction",
      "display": "Adverse reaction",
      "definition": "An adverse reaction is expected or its risk is increased."
    },
    {
      "code": "additive-adverse-effects",
      "display": "Additive adverse effects",
      "definition": "Adverse or undesirable effects are expected to be additive for one or more implicated therapies."
    },
    {
      "code": "avoid-concurrent-use",
      "display": "Avoid concurrent use when possible",
      "definition": "Concurrent use should generally be avoided because of the identified clinical risk."
    },
    {
      "code": "contraindicated-in-some-patients",
      "display": "Contraindicated in some patients",
      "definition": "Concurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances."
    }
  ]
}